Case Reports in Critical Care

Case Reports in Critical Care / 2011 / Article

Case Report | Open Access

Volume 2011 |Article ID 291934 | 3 pages | https://doi.org/10.1155/2011/291934

Development of ARDS after Excessive Kath Consumption: A Case Report

Academic Editor: M. Doganay
Received18 Jun 2011
Accepted11 Jul 2011
Published07 Sep 2011

Abstract

Khat is a drug widely used in the Horn of Africa and the Arabian Peninsula. Khat leaves contain, among other substances, the psychoactive alkaloid cathinone, which induce central nervous system stimulation leading to euphoria, hyperactivity, restlessness, and insomnia. However, it also could cause psychological adverse effects such as lethargy, sleepiness, psychoses, and depression necessitating pharmacologic treatment. Here we report the case of a 35-year-old man from Somalia who became unconscious and developed aspiration pneumonia and subsequent ARDS after excessive consumption of khat leaves. His unconsciousness was possibly caused by the sleepiness developed after khat consumption and a benzodiazepine intake by the patient himself. Thus, khat-induced adverse effects should not primarily be treated pharmacologically, but patients should be urged to quit khat consumption in order to eliminate or, at least, reduce the severity of present psychological adverse effects.

1. Introduction

Khat (Catha edulis Frosk.) is a scrub native in the Horn of Africa and the Arabian Peninsula. In these areas chewing its fresh leaves is widespread as a social habit, leading to euphoria, alertness via central nervous system stimulation [1]. Therefore, khat was used traditionally to relieve fatigue, and it had occupied some place in self-medication of obesity and depression [1, 2]. As a result of migration khat has gained global availability [1]. For the present, the prevalence of khat chewing in Western countries appears to be restricted to the immigrant communities from these countries [3]. However, there is some evidence that khat use has spread to the host population also, and a pill containing an extract of khat leaves, known as “Hagigat,” has been sold to Israeli drug users [4, 5].

The mentioned central stimulant actions are evoked primarily by cathinone, the main active alkaloid in fresh picked leaves, and it is structurally similar to D-amphetamine [1]. Cathinone is considered as an indirectly acting sympathomimetic alkaloid having catecholamine-releasing properties at both central serotoninergic and dopaminergic synapses as well as at peripheral noradrenaline storage sites [6]. It is structurally similar to amphetamine and operates through the same mechanism [7]. Thus, cathinone induces pronounced behavioral effects including euphoria, excitability, anxiety, irritability, hyperactivity, restlessness, and insomnia in a dose-related manner [8, 9]. This is followed by lethargy and sleepiness in the next morning. Khat usage is also associated with memory impairment, depression, psychoses, and psychological dependence [9, 10]. However, khat chewing not only affects the central nervous system, but also impairs other organ systems like the cardiovascular and the cerebrovascular system, the gastrointestinal tract, and the liver as well as other peripheral organ systems [1, 6]. Thus, khat chewing is able to cause substantial health damage, and it could have social, financial as well as medical consequences [3, 11]. Here we present a case report of a 35-year-old male who developed aspiration pneumonia with subsequent ARDS after excessive consumption of khat leaves.

2. Case Presentation

A 35-year-old male patient was admitted to our medical intensive care unit (ICU) because of multiple organ failure.

The patient was born in Somalia and migrated to Austria six years ago. In his past history there were tuberculosis detectable about 15 years ago, which was treated successfully, and unspecific heart problems. Because of insomnia and depression, a tricyclic antidepressant (amitriptyline) and diazepam were prescribed. In addition, every day the patient chewed khat leaves. According to his next of kin, khat intake increased considerably during the past few days before hospital admission. In this context, they reported that the patient was sleeping nearly until noon. However, on the day of hospital admission it was difficult to rouse the patient even in the early afternoon. Hence, an emergency physician was called to the patient, who found him neurologically disturbed with the risk of aspiration. Thus, the patient was sedated, intubated, and transferred to the emergency department (ED) of our hospital thereafter. A CT scan of the brain was performed to exclude any underlying structural cause within the brain for the present unconsciousness. At the ED an electrocardiogram showed arterial fibrillation with a heart rate of 143 bpm. Conversion into sinus tachycardia was achieved spontaneously within six hours subsequently. Hemodynamics was stable during that time period. However, gas exchange was considerably compromised. After the performance of bronchoscopy, which showed no foreign bodies or massive secretions but reddened mucosa indicating aspiration of gastric acid, the patients was transferred to our medical ICU. Further clinical and laboratory data at ED admission as well as at ICU admission are presented in Table 1.


Normal rangeED admissionICU admission

HR, bpm143117
MAP, mmHg6577
PaO2/FiO272,7120
Body temperature, °C38.137.9
Lactate, mmol/L0.5–1.63.41.4
Creatinine, mg/dl<1.21.951.41
GOT, U/L<35202290
GPT, U/L<45248320
gGT, U/L<55316238
CK, U/L<19010141553
Troponin T, ng/ml0–0.030.274Na
CRP, mg/dl<15.519.27
WBC, G/L4.0–10.010.358.77

At ICU admission SOFA score was found to be 8, and SAPS II score was 46. Hemodynamic condition was stable without catecholamine support. Moreover, during ICU stay the patient developed arterial hypertension, which was treated accordingly. The patient remained intubated and under analgosedation (combined propofol and remifentanil administration) administered continuously. Pulmonary function remained significantly compromised due to present aspiration pneumonia, which proceeded into ARDS over the next few days. Therefore, transient prone positioning of the patient was performed. However, gas exchange improved under antibiotic therapy that the patient could be extubated after two weeks of mechanical ventilation.

After the cessation of the mechanical ventilation the patient showed massive agitation indicating present delirium, which could be improved by the administration of clonidine as well as lorazepam and trazodone. Finally, the patient was discharged from the ICU after 22 days and discharged from the hospital in good condition another 14 days thereafter.

3. Discussion

Khat chewing is widely practiced in the Horn of Africa and the Arabian Peninsula. Nonetheless, due to easy transportation and easing of importation restrictions khat is spreading to Western countries in recent years [1, 3]. Khat leaves contain cathinone, a psychoactive alkaloid, which is structurally similar to amphetamine [1]. Thus, it induces pronounced behavioral effects by stimulation of the central nervous system [8, 9]. However, it provokes systemic adverse effects on different organ systems such as psychological or cardiovascular as well [1, 9]. Thus, cathinone could entail substantial damage of health accompanied by grave social and economical consequences [1, 3, 6, 10].

Our patient presented atrial fibrillation with a heart rate up to 143 bpm. Tachycardia and cardial arrhythmias are well known adverse effects seen in khat users [9]. These adverse effects are possibly caused by stimulation of trace amine-associated receptors by cathinone [1, 12].

Cathinone, a psychoactive alkaloid found in khat leaves, also has a stimulating effect on the central nervous system inducing psychological sensations such as euphoria, hyperactivity, restlessness, and insomnia [8, 9]. However, these symptoms are followed by lethargy and sleepiness. Because of these side effects, which can be observed in the morning after khat consumption, the family of the patients was not concerned that he was sleeping during the whole morning. Since it was difficult to rouse the patient even in the early afternoon an emergency physician was called, who found the patient comatose with insufficient adverse effects reflexes. Thus, the patient was intubated and transferred to the ED, where an underlying cause located in the central nervous system was excluded by a CT scan of the brain. A chest X-ray, however, showed an infiltration in the left-sided lower lobe of the lungs conformable with aspiration pneumonia. This pneumonia progressed to ARDS over the next few days necessitating prolonged artificial ventilation accompanied with intermittent prone positioning of the patient.

Nonetheless, there are no reports that khat could induce coma in chronic khat consumers, which would explain aspiration seen in our patient as a single cause. Thus, it is likely that the prescribed medication of the patient was also responsible for that disturbance to a certain extent. Due to pre existing depression as well as insomnia amitriptyline and diazepam have been prescribed several times before the accident. Amitriptyline was taken regularly, which was confirmed at admission by a plasma concentration within the normal range. Nonetheless, the patient used additional diazepam on demand in order to calm himself after excessive khat use. Thus, it is possible that the combination of sleepiness after khat consumption and an intake of diazepam effectuated coma, which caused aspiration to the lungs subsequently.

Insomnia, psychoses as well as depressive mood are known adverse effects of khat consumption [810]. Thus, one should prescribe hypnotic drugs very carefully to treat these adverse effects, because such drugs could potentiate lethargy and sleepiness, which could lead to unconsciousness. Patients should be urged to quit khat consumption in order to eliminate or, at least, reduce the severity of the mentioned psychological disorders and khat-induced adverse effects should not primarly be treated pharmacologically.

References

  1. A. Al-Motarreb, M. Al-Habori, and K. J. Broadley, “Khat chewing, cardiovascular diseases and other internal medical problems: the current situation and directions for future research,” Journal of Ethnopharmacology, vol. 132, no. 3, pp. 540–548, 2010. View at: Publisher Site | Google Scholar
  2. N. Deyessa, Y. Berhane, A. Alem, U. Hogberg, and G. Kullgren, “Depression among women in rural Ethiopia as related to socioeconomic factors: a community-based study on women in reproductive age groups,” Scandinavian Journal of Public Health, vol. 36, no. 6, pp. 589–597, 2008. View at: Publisher Site | Google Scholar
  3. R. A. Manghi, B. Broers, R. Khan, D. Benguettat, Y. Khazaal, and D. F. Zullino, “Khat use: Lifestyle or addiction?” Journal of Psychoactive Drugs, vol. 41, no. 1, pp. 1–10, 2009. View at: Google Scholar
  4. A. Holligan, “Khat use spreads to British youth,” BBC World service, online news, March 2009, http://news.bbc.co.uk/2/hi/uk_news/7942432.stm. View at: Google Scholar
  5. Y. Bentur, A. Bloom-Krasik, and B. Raikhlin-Eisenkraft, “Illicit cathinone (“Hagigat”) poisoning,” Clinical Toxicology, vol. 46, no. 3, pp. 206–210, 2008. View at: Publisher Site | Google Scholar
  6. A. Al-Motarreb, S. Briancon, N. Al-Jaber et al., “Khat chewing is a risk factor for acute myocardial infarction: a case-control study,” British Journal of Clinical Pharmacology, vol. 59, no. 5, pp. 574–581, 2005. View at: Publisher Site | Google Scholar
  7. P. Kalix, “Cathinone, a natural amphetamine,” Pharmacology and Toxicology, vol. 70, no. 2, pp. 77–86, 1992. View at: Google Scholar
  8. G. Cox and H. Rampes, “Adverse effects of khat: a review,” Advances in Psychiatric Treatment, vol. 9, no. 6, pp. 456–463, 2003. View at: Publisher Site | Google Scholar
  9. E. E. Balint, G. Falkay, and G. A. Balint, “Khat—a controversial plant,” Wiener Klinische Wochenschrift, vol. 121, no. 19-20, pp. 604–614, 2009. View at: Publisher Site | Google Scholar
  10. P. Houghton, “Khat—a growing concern in the UK,” Pharmaceutical Journal, vol. 272, no. 7285, pp. 163–165, 2004. View at: Google Scholar
  11. WHO Expert Committee on Drug Dependence, 34 report, WHO technical report series 942, Geneva, Switzerland, 2006.
  12. J. R. Bunzow, M. S. Sonders, S. Arttamangkul et al., “Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor,” Molecular Pharmacology, vol. 60, no. 6, pp. 1181–1188, 2001. View at: Google Scholar

Copyright © 2011 Marlene Wewalka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1414 Views | 740 Downloads | 2 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.